Africa Malaria Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 51.35 million |
 Market Size (Forecast Year) |
USD 64.78 million |
 CAGR |
% |
| Major Markets Players |
>非洲疟疾治疗市场，按药剂（恶性疟原虫、间日疟原虫、卵形疟原虫、三日疟原虫、诺氏疟原虫）、类型（药物、疫苗接种、其他）、治疗类型（抑制治疗、根治治疗）、药物类型（仿制药、品牌药）、给药途径（口服、肠外）、最终用户（医院、专科诊所、家庭医疗保健、其他）、分销渠道（直接招标、医院药房、零售药房、网上药房、其他）划分 - 行业趋势和预测到 2031 年。
非洲疟疾治疗市场分析和规模
疟疾是一种传染病，通过被感染的雌性按蚊叮咬传播，将寄生虫转移到人体中。此外，这些寄生虫会寄居在肝细胞中，在那里繁殖和生长。推动非洲疟疾治疗市场的主要因素是政府提高认识的举措和新型抗疟药物研究的激增。然而，发展中国家缺乏医疗保健意识是制约市场增长的主要因素。羟氯喹和氯喹的生产、进口和出口增加预计将为市场带来机遇。抗疟药物的不良反应和风险预计将对市场构成挑战。
Data Bridge Market Research 分析，非洲疟疾治疗市场规模在 2023 年为 5135 万美元，到 2031 年可能达到 6478 万美元，预计在预测期内的复合年增长率为 6.4%。由于人们越来越关注疫苗接种计划和活动，“疫苗接种”在疟疾治疗市场类型细分中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
病原体（恶性疟原虫、间日疟原虫、卵形疟原虫、三日疟原虫、诺氏疟原虫）、类型（药物、疫苗接种、其他）、治疗类型（抑制性治疗、根治性治疗）、药物类型（仿制药、品牌药）、给药途径（口服、肠胃外）、最终用户（医院、专科诊所、家庭医疗保健、其他）、分销渠道（直接招标、医院药房、零售药房、网上药房、其他） |
|
覆盖国家 |
尼日利亚、刚果民主共和国、乌干达、尼日尔、科特迪瓦、肯尼亚、南非、埃及、非洲其他地区 |
|
涵盖的市场参与者 |
Hikma Pharmaceuticals PLC（英国）、Sun Pharmaceutical Industries Ltd.（印度）、Zydus Cadila（印度）、Cipla Inc.（印度）、GlaxoSmithKline plc。 （英国）、Bliss GVS Pharma Ltd.（印度）、MMV（瑞士）、Novartis AG（瑞士）、Taj Pharmaceuticals Limited（印度）、Lupin Pharmaceuticals, Inc.（Lupin Limited 的子公司）（印度）、AJANTA PHARMA（印度）、Strides Pharma Science Limited（印度）、赛诺菲-安万特美国有限责任公司（Sanofi-aventis US LLC）（赛诺菲 (Sanofi)（法国）、Viatris Inc.（美国） |
|
市场机会 |
|
市场定义
疟疾治疗涉及多管齐下的方法，旨在对抗通过蚊虫叮咬传播的疟原虫引起的寄生虫感染。主要目标是从血液中清除寄生虫并预防并发症。通常，抗疟药物的使用取决于寄生虫的种类和感染的严重程度。青蒿素类联合疗法 (ACT) 通常是一线药物，因为它们能有效针对寄生虫的生命周期。根据药物耐药模式，可能会使用其他药物，如氯喹、奎宁或阿托伐醌-氯胍。
非洲疟疾治疗市场动态
驱动程序
- 科技进步日新月异
诊断工具的改进和治疗方法的创新等技术进步推动了疟疾治疗的进步。快速诊断检测 (RDT)、即时诊断设备和移动医疗解决方案的普及可以彻底改变疟疾的诊断和管理。
- 医疗基础设施改善
加强医疗基础设施，特别是在医疗资源匮乏的农村地区，为提高优质医疗服务的可及性提供了机会。建设诊所、培训医护人员和确保基本医疗用品的供应可以显著影响疟疾治疗效果。
机会
- 药物研发创新
制药公司和研究人员有机会开发新的、更有效的抗疟药物。投资研发可以发现对抗耐药菌株且副作用较少的新型化合物，从而有可能彻底改变疟疾治疗。
- 加强公私伙伴关系
政府、非政府组织、慈善基金会和私营企业之间的合作提供了汇集资源和专业知识的机会。公私伙伴关系可以促进研究、基础设施建设以及药物和蚊虫控制措施的分发资金。
限制
- 监管批准和合规性
非洲国家的监管机构负责批准和注册药品，确保药品符合安全性和有效性标准。然而，不同国家不同的监管框架可能会给制药公司同时向多个市场推出新药带来障碍。审批延迟会影响潜在有益药物的供应。
- 耐药性
疟原虫耐药菌株的出现是一大障碍。对氯喹和磺胺多辛-乙胺嘧啶等常用抗疟药物的耐药性使治疗变得复杂，并迫使人们采用更昂贵、更复杂的疗法。
挑战
- 诊断限制
准确及时地诊断疟疾对于有效治疗至关重要。然而，获得可靠的诊断工具是一项挑战，特别是在偏远地区。快速诊断测试（RDT）并不总是随时可用或负担得起，导致误诊或延误治疗。
本疟疾治疗市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关疟疾治疗市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
最新动态
- 2018 年 2 月，Cipla Ltd. 的 100 毫克直肠青蒿琥酯栓剂 (RAS) 获得世界卫生组织 (WHO) 资格预审计划的批准。该产品用于严重疟疾的转诊前管理。这促进了该公司的市场增长
- 2018 年 7 月，Lupin Pharmaceuticals, Inc. 宣布其硫酸羟氯喹片获得美国食品药品监督管理局 (FDA) 批准。该批准加速了该公司的增长轨迹，特别是从长远来看，预计将加强其在市场上的地位
非洲疟疾治疗市场范围
非洲疟疾治疗市场根据药剂、类型、治疗方法、药物类型、给药途径、最终用户和分销渠道分为七个显著的部分。
代理人
- 恶性疟原虫
- 间日疟原虫
- P. 奥瓦勒
- 三日疟原虫
- P. Knowlelsi。
类型
- 药物
- 疫苗接种
- 其他的
治疗
- 抑制治疗
- 根治性治疗
药物类型
- 品牌
- 泛型
给药途径
- 口服
- 肠外
最终用户
- 医院
- 专科诊所
- 家庭医疗保健
- 其他的
分销渠道
- 直接招标
- 医院药房
- 零售药店
- 网上药店
- 其他的
疟疾治疗市场国家分析/见解
非洲疟疾治疗市场根据药剂、类型、治疗方法、药物类型、给药途径、最终用户和分销渠道分为七个显著的部分。
市场报告涉及的国家包括尼日利亚、刚果民主共和国、乌干达、哥斯达黎加、尼日尔、肯尼亚、埃及、南非和非洲其他国家。
由于患者人数的快速增加和技术的进步，预计尼日利亚将占据主导地位并以最有希望的增长速度增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战，销售渠道的影响。
竞争格局和非洲疟疾治疗市场份额分析
非洲疟疾治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对非洲疟疾治疗市场的关注有关。
非洲疟疾治疗市场的一些主要参与者是：
- Hikma Pharmaceuticals PLC（英国）
- 太阳制药工业有限公司 (印度)
- Zydus Cadila（印度）
- Cipla Inc.（印度）
- 葛兰素史克公司（英国）
- Bliss GVS Pharma Ltd.（印度）
- MMV（瑞士）
- 诺华公司（瑞士）
- 泰姬制药有限公司 (印度)
- Lupin Pharmaceuticals, Inc.（Lupin Limited 的子公司）（印度）
- 阿旃陀制药（印度）
- Strides Pharma Science Limited（印度）
- sanofi-aventis US LLC（赛诺菲子公司）（法国）
- Viatris Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of AFRICA MALARIA TREATMENT MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market end user coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- AFRICA MALARIA TREATMENT MARKET: REGULATIONS
- Summary write-up (Africa)
- Pipeline analysis
- Market Overview
- Drivers
- High prevalence and disease burden of malaria in Africa
- Rise in medical insurance
- Humid climatic conditions and rising number of mosquitoES (Anopheles gambiae complex) in certain parts of Africa
- Restraints
- Adverse effects and risks associated with antimalariaL drugs
- Lack of awareness related to symptoms of malaria
- Low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment
- OpportunitIES
- strategic initiatives by major players
- increasing launch of new products
- Increase in production and export as well as import of hydroxychloroquine and chloroquine
- Challenges
- Regulatory challenges to antimalarial drug approval
- Achieving universal access
- COVID-19 IMPACT ON THE AFRICA MALARIA TREATMENT MARKET
- PRICE IMPACT
- IMPACT ON SUPPLY CHAIN
- IMPACT ON DEMAND
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- africa malaria treatment MARKET, By agent
- overview
- Plasmodium Falciparum
- P. Vivax
- P. Ovale
- P. Malariae
- P. Knowlelsi
- AFRICA MALARIA TREATMENT MARKET, By type
- overview
- medication
- Chloroquine
- Primaquine
- Artemisinin-Based Combination Therapy (ACT)
- ARTEMETHER–LUMEFANTRINE
- ARTESUNATE-AMODIAQUINE
- DIHYDROARTEMISININ-PIPERAQUINE
- OTHERS
- Quinine
- Hydroxychloroquine
- Mefloquine
- Non-Artemisinin Based Combinations (Non-ACTs)
- SULFADOXINE-PYRIMETHAMINE WITH CHLOROQUINE
- SULFADOXINE-PYRIMETHAMINE WITH AMODIAQUINE
- OTHERS
- Others
- vaccination
- Rts,S/As01
- Pfspz
- Others
- AFRICA MALARIA TREATMENT MARKET, By treatment type
- overview
- Suppressive Treatment
- Radical Treatment
- AFRICA MALARIA TREATMENT MARKET, By Drug Type
- overview
- generics
- branded
- Artefan
- Coartem
- Riamet
- Malarone
- Eurartesim
- Lonart
- Others
- AFRICA MALARIA TREATMENT MARKET, By route of administration
- overview
- oral
- Parenteral
- Intravenous
- Intramuscular
- Subcutaneous
- AFRICA MALARIA TREATMENT MARKET, By end user
- overview
- hospitals
- Specialty Clinics
- Home Healthcare
- others
- AFRICA MALARIA TREATMENT MARKET, By distribution channel
- overview
- direct tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Africa malaria treatment market, BY Country
- NIGERIA
- DEMOCRATIC REPUBLIC OF THE CONGO
- UGANDA
- NIGER
- CÔTE D’IVOIRE
- KENYA
- SOUTH AFRICA
- EGYPT
- REST OF AFRICA
- Africa MALARIA TREATMENT Market: COMPANY landscape
- company share analysis: Africa
- swot analysis
- company profile
- Novartis AG
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- cipla inc.
- COMPANY SNAPSHOT
- Revenue analysis
- company share analysis
- product portfolio
- RECENT DEVELOPMENTS
- Strides Pharma Science Limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Hikma Pharmaceuticals PLC
- COMPANY SNAPSHOT
- revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- Recent development
- Sun Pharmaceutical Industries Ltd.
- COMPANY SNAPSHOT
- Revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- AJANTA PHARMA.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Bliss GVS Pharma Ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- GlaxoSmithKline plc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Lupin Pharmaceuticals, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- MMV
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- sanofi-aventis U.S. LLC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Taj Pharmaceuticals Limited
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Viatris Inc.
- COMPANY SNAPSHOT
- Revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Zydus Cadila
- COMPANY SNAPSHOT
- revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- Recent development
- questionnaire
- related reports
表格列表
TABLE 1 Africa malaria treatment Market, pipeline analysis
TABLE 2 ESTIMATED Malaria Cases and Deaths, by Region, 2018
TABLE 3 Regulatory Challenges to Antimalarial Drug Approval.
TABLE 4 Challenges and problems that drive the R&D framework
TABLE 5 AFRICA MALARIA TREATMENT MARKET, By Agent, 2019-2028 (USD thousand)
TABLE 6 Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 7 Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 8 Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 9 Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 10 Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 11 Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 12 Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 13 Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 14 Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 15 Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 16 Africa Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)
TABLE 17 Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 18 Africa Malaria treatment Market, By country, 2019-2028 (USD Thousand)
TABLE 19 Nigeria Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 20 Nigeria Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 21 Nigeria Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 22 Nigeria Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 23 Nigeria Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 24 Nigeria Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 25 Nigeria Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 26 Nigeria Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 27 Nigeria Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 28 Nigeria Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 29 Nigeria Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 30 Nigeria Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 31 Nigeria Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 32 Democratic Republic of the Congo Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 33 Democratic Republic of the Congo Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 34 Democratic Republic of the Congo Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 35 Democratic Republic of the Congo Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 36 Democratic Republic of the Congo Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 37 Democratic Republic of the Congo Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 38 Democratic Republic of the Congo Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 39 Democratic Republic of the Congo Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 40 Democratic Republic of the Congo Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 41 Democratic Republic of the Congo Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 42 Democratic Republic of the Congo Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 43 Democratic Republic of the Congo Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)
TABLE 44 Democratic Republic of the Congo Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 45 Uganda Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 46 Uganda Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 47 Uganda Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 48 Uganda Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 49 Uganda Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 50 Uganda Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 51 Uganda Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 52 Uganda Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 53 Uganda Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 54 Uganda Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 55 Uganda Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 56 Uganda Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 57 Uganda Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 58 Niger Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 59 Niger Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 60 Niger Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 61 Niger Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 62 Niger Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 63 Niger Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 64 Niger Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 65 Niger Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 66 Niger Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 67 Niger Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 68 Niger Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 69 Niger Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 70 Niger Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 71 Côte d’Ivoire Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 72 Côte d’Ivoire Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 73 Côte d’Ivoire Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 74 Côte d’Ivoire Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 75 Côte d’Ivoire Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 76 Côte d’Ivoire Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 77 Côte d’Ivoire Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 78 Côte d’Ivoire Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 79 Côte d’Ivoire Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 80 Côte d’Ivoire Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 81 Côte d’Ivoire Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 82 Côte d’Ivoire Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 83 Côte d’Ivoire Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 84 Kenya Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 85 Kenya Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 86 Kenya Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 87 Kenya Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 88 Kenya Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 89 Kenya Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 90 Kenya Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 91 Kenya Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 92 Kenya Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 93 Kenya Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 94 Kenya Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 95 Kenya Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 96 Kenya Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 97 South Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 98 South Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 99 South Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 100 South Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 101 South Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 102 South Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 103 South Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 104 South Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 105 South Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 106 South Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 107 South Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 108 South Africa Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 109 South Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 110 Egypt Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 111 Egypt Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 112 Egypt Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 113 Egypt Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 114 Egypt Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 115 Egypt Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 116 Egypt Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 117 Egypt Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 118 Egypt Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 119 Egypt Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 120 Egypt Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 121 Egypt Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 122 Egypt Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 123 Rest of Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
图片列表
FIGURE 1 Africa malaria treatment MARKET: segmentation
FIGURE 2 AFRICA MALARIA TREATMENT MARKET: data triangulation
FIGURE 3 AFRICA MALARIA TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 AFRICA MALARIA TREATMENT MARKET: REGIONAL vs COUNTRY MARKET ANALYSIS
FIGURE 5 AFRICA MALARIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 AFRICA MALARIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 AFRICA MALARIA TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 AFRICA MALARIA TREATMENT MARKET: MARKET end user COVERAGE GRID
FIGURE 9 AFRICA MALARIA TREATMENT MARKET: vendor share analysis
FIGURE 10 AFRICA MALARIA TREATMENT MARKET: SEGMENTATION
FIGURE 11 increasing prevalence of MALARIA, RISING MEDICAL HEALTHCARE INSURANCE, AND humid climatic conditions in africa are expected to drive THE AFRICA MALARIA TREATMENT MARKET IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 Plasmodium Falciparum segment is expected to account for the largest share of the AFRICA MALARIA TREATMENT MARKET in 2021 and 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AFRICA MALARIA TREATMENT MARKET
FIGURE 14 Malaria Cases in 10 highest-burden countries in Africa, 2010-2017
FIGURE 15 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2020
FIGURE 16 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2019-2028 (USD thousand)
FIGURE 17 AFRICA MALARIA TREATMENT MARKET: By AGENT, CAGR (2021-2028)
FIGURE 18 AFRICA MALARIA TREATMENT MARKET: By AGENT, LIFELINE CURVE
FIGURE 19 AFRICA MALARIA TREATMENT MARKET: By type, 2020
FIGURE 20 AFRICA MALARIA TREATMENT MARKET: By type, 2019-2028 (USD thousand)
FIGURE 21 AFRICA MALARIA TREATMENT MARKET: By type, CAGR (2021-2028)
FIGURE 22 AFRICA MALARIA TREATMENT MARKET: By type, LIFELINE CURVE
FIGURE 23 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2020
FIGURE 24 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2019-2028 (USD thousand)
FIGURE 25 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, CAGR (2021-2028)
FIGURE 26 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, LIFELINE CURVE
FIGURE 27 AFRICA MALARIA TREATMENT MARKET: By drug type, 2020
FIGURE 28 AFRICA MALARIA TREATMENT MARKET: By drug type, 2019-2028 (USD thousand)
FIGURE 29 AFRICA MALARIA TREATMENT MARKET: By drug type, CAGR (2021-2028)
FIGURE 30 AFRICA MALARIA TREATMENT MARKET: By drug type, LIFELINE CURVE
FIGURE 31 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2020
FIGURE 32 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2019-2028 (USD thousand)
FIGURE 33 AFRICA MALARIA TREATMENT MARKET: By route of administration, CAGR (2021-2028)
FIGURE 34 AFRICA MALARIA TREATMENT MARKET: By route of administration, LIFELINE CURVE
FIGURE 35 AFRICA MALARIA TREATMENT MARKET: By end user, 2020
FIGURE 36 AFRICA MALARIA TREATMENT MARKET: By end user, 2019-2028 (USD thousand)
FIGURE 37 AFRICA MALARIA TREATMENT MARKET: By end user, CAGR (2021-2028)
FIGURE 38 AFRICA MALARIA TREATMENT MARKET: By end user, LIFELINE CURVE
FIGURE 39 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2020
FIGURE 40 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2019-2028 (USD thousand)
FIGURE 41 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 42 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 Africa Malaria treatment MARKET: SNAPSHOT (2020)
FIGURE 44 Africa Malaria treatment MARKET: BY COUNTRY (2020)
FIGURE 45 Africa Malaria treatment MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 Africa Malaria treatment MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 Africa Malaria treatment MARKET: BY Agent (2021-2028)
FIGURE 48 Africa MALARIA TREATMENT Market: company share 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
